Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Moodys
Colorcon
Boehringer Ingelheim
McKinsey
Express Scripts
Dow

Last Updated: December 5, 2019

DrugPatentWatch Database Preview

Drugs in MeSH Category Antidiarrheals

See Plans and Pricing

« Back to Dashboard

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Janssen Pharms IMODIUM loperamide hydrochloride SOLUTION;ORAL 019037-001 Jul 31, 1984 DISCN No No   Start Trial   Start Trial   Start Trial
J And J Consumer Inc IMODIUM A-D loperamide hydrochloride TABLET;ORAL 019860-001 Nov 22, 1989 OTC Yes Yes   Start Trial   Start Trial   Start Trial
J And J Consumer Inc IMODIUM A-D loperamide hydrochloride SOLUTION;ORAL 019487-001 Mar 1, 1988 OTC Yes Yes   Start Trial   Start Trial   Start Trial
Ohm Labs LOPERAMIDE HYDROCHLORIDE loperamide hydrochloride TABLET;ORAL 074091-001 Dec 10, 1992 OTC No No   Start Trial   Start Trial   Start Trial
Roxane LOPERAMIDE HYDROCHLORIDE loperamide hydrochloride CAPSULE;ORAL 073080-001 Nov 27, 1991 DISCN No No   Start Trial   Start Trial   Start Trial
Perrigo R And D LOPERAMIDE HYDROCHLORIDE loperamide hydrochloride SUSPENSION;ORAL 091292-001 May 20, 2011 OTC No No   Start Trial   Start Trial   Start Trial
Bionpharma Inc LOPERAMIDE HYDROCHLORIDE loperamide hydrochloride CAPSULE;ORAL 021855-002 Aug 4, 2005 OTC Yes Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Express Scripts
McKinsey
Colorcon
AstraZeneca
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.